|
|
|
메뉴
|
 |
| |
 |
 |
| |
|
Sotalol hydrochloride 40mg, 160mg |
|
|
| |
 |
| |
Symptomatic and treatment requiring supraventricular
tachycardiac arrhythmia
Severe symptomatic ventricular tachycardiac
arrythmia |
|
|
| |
 |
| |
The initial-therapy with Rentibloc 40 : 2-3 x 40mg /
day
The maintenance-therapy with Rentibloc 160 : up to 3
x 160mg / day |
|
|
| |
 |
| |
|
The most important adverse effects are torsade de
pointes and other serious new ventricular
arrhythmias, occurring at rates almost 4% and 1%,
respectively, in the VT/VF population. |
|
|
| |
 |
|
|
|
Rentibloc tab. is contraindicated in patients with
bronchial asthma, sinus bradycardia, second and
thied degree AV block, unless a functional pacemaker
is present, congenital or acquired long QT
syndromes, cardiogenic shock, uncontrolled
congestive heart failure, and previous evidence of
hypersensitivity to Rentibloc. |
|
|
| |
 |
| |
|
Renal
impairment : sotalol hydrochloride is mainly
eliminated via the kidneys through glomerular
filtration and to a small degree by tubular
secretion. There is a direct relationship
between renal function, as measured by serum
creatinine or creatinine clearance, and the
elimination rate of sotalol. |
|
|
|
|
|
|
|
